Incorporating clinical measures, such as NIHSS scores, stroke risk factors, baseline functional status, and stroke mechanisms, to provide a more comprehensive understanding of the comparative safety and efficacy of IV-tPA and EVT. The gene discussed is PLAT; the disease is stroke disorder.